Patents-Review.com
🔗 Permalink
Inventor profile of:

Dawei Cui

City:

Shanghai

Country:

China

Published Applications:

26

Last publication date:

2026-01-15

Top Assignees for applications by Dawei Cui

The entities that hold a legal rights for patent applications filed by inventor Cui Dawei:

Recent patent applications by Cui Dawei

Dawei Cui from Shanghai, CN has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-01-15
US20260015363A1
Chemistry; metallurgy

SUBSTITUTED PYRIMIDINE-FUSED RING INHIBITOR, METHOD FOR PREPARING SAME, AND USE THEREOF

 #2 | 2025-06-26
US20250206758A1
Chemistry; metallurgy

SUBSTITUTED BRIDGED RING INHIBITOR, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

 #3 | 2025-05-08
US20250144093A1
Human necessities

PYRUVATE KINASE ACTIVATORS FOR USE IN TREATING BLOOD DISORDERS

 #4 | 2024-10-10
US20240336606A1
Chemistry; metallurgy

SUBSTITUTED BENZO OR PYRIDOPYRIMIDINE AMINE INHIBITOR, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF

 #5 | 2024-02-22
US20240059733A1
Chemistry; metallurgy

THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE

 #6 | 2024-01-04
US20240002362A1
Chemistry; metallurgy

DEUTERATED 2-ARYLHETEROCYCLE-3-OXO-2,3- DIHYDROPYRIDAZINE-4-CARBOXAMIDE INHIBITOR AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

 #7 | 2023-07-20
US20230226055A1
Human necessities

Pyruvate kinase activators for use in treating blood disorders

 #8 | 2023-04-20
US20230118795A1
Chemistry; metallurgy

ARYL OR HETEROARYL PYRIDONE OR PYRIMIDINE DERIVATIVE, PREPARATION METHOD AND USE THEREOF

 #9 | 2023-04-06
US20230105745A1
Chemistry; metallurgy

CYCLOALKYL AND HETERO-CYCLOALKYL INHIBITORS, PREPARATION METHODS THEREFOR, AND USE THEREOF

 #10 | 2022-12-15
US20220395503A1
Human necessities

Pyruvate kinase activators for use in treating blood disorders

 #11 | 2022-10-04
US17303762
Chemistry; metallurgy

Cycloalkyl and hetero-cycloalkyl inhibitors, preparation methods therefor, and use thereof

 #12 | 2022-07-28
US20220233541A1
Human necessities

Pyruvate kinase modulators and use thereof

 #13 | 2021-05-06
US20210130371A1
Chemistry; metallurgy

Pyruvate kinase activators for use in treating blood disorders

 #14 | 2021-03-18
US20210077490A1
Human necessities

Pyruvate kinase activators for use in treating blood disorders

 #15 | 2021-01-28
US20210024575A1
Chemistry; metallurgy

Therapeutically active compounds and their methods of use

 #16 | 2020-10-29
US20200339626A1
Chemistry; metallurgy

Therapeutically active compounds and their methods of use

 #17 | 2020-07-02
US20200207785A1
Chemistry; metallurgy

Pyruvate kinase activators for use in treating blood disorders

 #18 | 2020-07-02
US20200206225A1
Human necessities

Pyruvate kinase modulators and use thereof

 #19 | 2019-10-17
US20190315802A1
Chemistry; metallurgy

Therapeutically active compounds and their methods of use

 #20 | 2019-01-24
US20190023737A1
Chemistry; metallurgy

Therapeutically active compounds and their methods of use

 #21 | 2018-07-12
US20180194802A1
Chemistry; metallurgy

Therapeutically active compositions and their methods of use

 #22 | 2017-03-02
US20170057994A1
Chemistry; metallurgy

THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE

 #23 | 2017-01-19
US20170015703A1
Chemistry; metallurgy

Therapeutically active compositions and their methods of use

 #24 | 2016-05-12
US20160130298A1
Chemistry; metallurgy

THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHODS OF USE

 #25 | 2015-01-29
US20150031627A1
Human necessities

THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE

 #26 | 2013-07-25
US20130190249A1
Human necessities

Therapeutically active compositions and their methods of use
InventorID:

355487 ⎘